HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Allosteric modulation of the GTPase activity of a bacterial LRRK2 homolog by conformation-specific Nanobodies.

Abstract
Mutations in the Parkinson's disease (PD)-associated protein leucine-rich repeat kinase 2 (LRRK2) commonly lead to a reduction of GTPase activity and increase in kinase activity. Therefore, strategies for drug development have mainly been focusing on the design of LRRK2 kinase inhibitors. We recently showed that the central RocCOR domains (Roc: Ras of complex proteins; COR: C-terminal of Roc) of a bacterial LRRK2 homolog cycle between a dimeric and monomeric form concomitant with GTP binding and hydrolysis. PD-associated mutations can slow down GTP hydrolysis by stabilizing the protein in its dimeric form. Here, we report the identification of two Nanobodies (NbRoco1 and NbRoco2) that bind the bacterial Roco protein (CtRoco) in a conformation-specific way, with a preference for the GTP-bound state. NbRoco1 considerably increases the GTP turnover rate of CtRoco and reverts the decrease in GTPase activity caused by a PD-analogous mutation. We show that NbRoco1 exerts its effect by allosterically interfering with the CtRoco dimer-monomer cycle through the destabilization of the dimeric form. Hence, we provide the first proof of principle that allosteric modulation of the RocCOR dimer-monomer cycle can alter its GTPase activity, which might present a potential novel strategy to overcome the effect of LRRK2 PD mutations.
AuthorsMargaux Leemans, Christian Galicia, Egon Deyaert, Elise Daems, Linda Krause, Jone Paesmans, Els Pardon, Jan Steyaert, Arjan Kortholt, Frank Sobott, Dagmar Klostermeier, Wim Versées
JournalThe Biochemical journal (Biochem J) Vol. 477 Issue 7 Pg. 1203-1218 (04 17 2020) ISSN: 1470-8728 [Electronic] England
PMID32167135 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2020 The Author(s).
Chemical References
  • Bacterial Proteins
  • Single-Domain Antibodies
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • GTP Phosphohydrolases
  • ras Proteins
Topics
  • Allosteric Regulation
  • Animals
  • Bacterial Proteins (metabolism)
  • Camelids, New World
  • Chlorobi (metabolism)
  • Drug Design
  • Escherichia coli (metabolism)
  • GTP Phosphohydrolases (metabolism)
  • Hydrolysis
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 (metabolism)
  • Mutation
  • Parkinson Disease (drug therapy, genetics)
  • Protein Domains
  • Protein Multimerization
  • Single-Domain Antibodies (metabolism)
  • ras Proteins (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: